Search

List Grid

841 - 850 of 982 Results

  • White House Releases FY20 Budget Request

    Fact Sheet

    The White House released its FY 2020 budget request to Congress on March 11, 2019, which includes significant cuts to global health programs compared to FY 2019 enacted levels (the overall levels in the request are similar to the FY 2019 budget request). Key highlights are as follows (see table for additional detail): Funding provided to the State Department and the U.S. Agency for International Development (USAID) (through the Global Health Programs account), which represents…

  • State Medicaid Programs Respond to Meet COVID-19 Challenges: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2020 and 2021

    Report

    This report provides an in-depth examination of the changes taking place in Medicaid programs across the country. The findings are drawn from the 20th annual budget survey of Medicaid officials in all 50 states and the District of Columbia conducted by KFF and Health Management Associates (HMA), in collaboration with the National Association of Medicaid Directors (NAMD). This report focuses on Medicaid policy changes planned for FY 2021, particularly those related to the COVID-19 pandemic.

  • FY19 Conference Agreement Released, Includes State & Foreign Operations (SFOPs) Funding

    Fact Sheet

    The FY19 Conference Agreement, which includes funding for State & Foreign Operations (SFOPs), was released on February 13, 2019. The SFOPs section of the bill includes funding for U.S. global health programs at the State Department and the U.S. Agency for International Development (USAID). Key highlights are as follows (see table for additional detail): Funding provided to the State Department and USAID through the Global Health Programs (GHP) account, which represents the bulk of global health…

  • Analysis Finds that Medications for Hepatitis C and HIV/AIDS Are the Costliest Group of Outpatient Prescription Drugs for Medicaid, While Diabetes Drugs Have Posted the Sharpest Rise in Costs 

    News Release

    Antiviral medications, including those that treat hepatitis C and HIV/AIDS, cost the Medicaid program more money (before rebates) than any other group of outpatient prescription drugs for each year from 2014 to 2017, according to a new KFF analysis. The analysis of utilization and spending trends finds that antivirals accounted for more than 13 percent of the $63.6 billion in Medicaid outpatient drug spending pre-rebates in 2017 -- a level disproportionate to their utilization and…

  • The U.S. Government Engagement in Global Health: A Primer

    Report

    This primer provides basic information about global health and U.S. government programs that address global health. The first several sections provide an overview of the field of global health and describe current global health issues. The subsequent sections describe U.S. government support for global health, from the programs the government supports, to the organization of the U.S. response, the budgets and financing of U.S. global health programs, and the U.S. government’s relationship with multilateral institutions…

  • Data Note: Public Awareness Around Antibiotic Resistance

    Issue Brief

    This data note examines the public’s knowledge and concerns about antibiotic resistance and also gauges the public’s experiences using antibiotics and their interactions with doctor and health care providers.

  • 2020 Employer Health Benefits Survey

    Report

    This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, offer rates, wellness programs, and employer practices. Annual premiums for employer-sponsored family health coverage reached $21,342 this year, up 4% from last year, with workers on average paying $5,588 toward the cost of their coverage.

  • Global HIV/AIDS Timeline

    Other Post

    The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.